The observed lower mortality with remdesivir plus dexamethasone in patients on IMV/ECMO "further supports the growing ...

Most patients with alopecia areata who had hair regrowth with baricitinib and discontinued maintenance therapy experienced a relapse of hair loss.

With alopecia areata in the headlines, Clinical Trials Arena looks at a potential shake-up in its drug options and an ...

Artificial intelligence is quickly becoming a valuable tool in the U.S. healthcare industry. Experts say a thoughtful ...

Tofacitinib (Xeljanz): Used for rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. Baricitinib (Olumiant): Approved for alopecia areata and rheumatoid arthritis. Ritlecitinib (Litfulo): ...

Lilly will license certain baricitinib manufacturing know-how to enable EVA Pharma to manufacture and supply treatment for various immunological diseases across 49 low- to middle-income countries ...

More than 75% of the cohort started a TNF inhibitor during the selected time frame. For the rest, JAK inhibitors were the ...

Incyte Corp's new patent details innovative methods for synthesizing baricitinib, a key rheumatoid arthritis treatment, enhancing pharmaceutical manufacturing processes.

The new research, however, suggests that existing drugs such as baricitinib and anakinra can disrupt the malfunctioning immune response and finally allow damaged lungs to heal. “Our collaboration with ...

The anti-inflammatory baricitinib is normally used to treat rheumatoid arthritis. Trials suggest it can cut death risk by about a fifth in patients needing hospital care for severe Covid.

On Friday, Aquestive Therapeutics, Inc. (NASDAQ:AQST) hosted a virtual investor day highlighting the company’s Anaphylm ...

Lilly will license certain baricitinib manufacturing know-how to enable EVA Pharma to manufacture and supply treatment for various immunological diseases across 49 low- to middle-income countries in ...